The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post hoc analysis of a phase III study to test the association between circulating methylated glutathione s transferase (mGSTP1) DNA levels and response to docetaxel (DTX) in metastatic castration resistant prostate cancer (mCRPC).
 
Kate Lynette Mahon
Travel, Accommodations, Expenses - Astellas Medivation
 
Wenjia Qu
No Relationships to Disclose
 
Hui-Ming Lin
No Relationships to Disclose
 
Calan Spielman
No Relationships to Disclose
 
Daniel Cain
Employment - OncoGenex
Stock and Other Ownership Interests - OncoGenex
 
Cindy Jacobs
Employment - OncoGenex
Stock and Other Ownership Interests - OncoGenex
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Endocyte; Ferring; Medivation; MorphoSys; Orion; Parexel
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Emergent BioSolutions; Endocyte; Ferring
 
Susan J. Clark
Patents, Royalties, Other Intellectual Property - Epigenomics
 
Lisa Horvath
Honoraria - Astellas Medivation
Research Funding - Astellas Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Medivation